{"id":"W2891720308","doi":"10.1200/jco.2017.35.15_suppl.7001","title":"Phase 3 randomized trial of momelotinib (MMB) versus best available therapy (BAT) in patients with myelofibrosis (MF) previously treated with ruxolitinib (RUX).","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Myelofibrosis; Clinical endpoint; Anemia; Internal medicine; Gastroenterology; Ruxolitinib; Randomized controlled trial; Surgery; Bone marrow","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001663321,0.001342717,0.002263628,0.0003667322,0.000449772,0.00127677,0.0009157961,0.001377671,0.009249083],"category_scores_gemma":[0.001700252,0.0005957854,0.001524916,0.00030922,0.0007909848,0.001055581,0.000409225,0.003505495,0.001331445],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008723493,"about_ca_system_score_gemma":0.001286836,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001077836,"about_ca_topic_score_gemma":0.003358131,"domain_scores_codex":[0.9995469,0.0002670674,0.00001840019,0.00006964564,0.0000293492,0.00006870263],"domain_scores_gemma":[0.9990676,0.000241192,0.0002151991,0.00005567641,0.00004489642,0.0003754617],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9793001,0.00572238,0.0006268987,0.0003191702,0.0005819491,0.00004533847,0.00003694047,0.0003607866,0.001739315,0.0001111408,0.001343625,0.00981235],"study_design_scores_gemma":[0.9489265,0.04773065,0.00147318,0.0000318539,0.0002130463,0.00005002474,0.00001781616,0.0005767834,0.0001893708,0.0001730654,0.0006070737,0.00001072597],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9769375,0.006091229,0.000867288,0.002100332,0.000960405,0.005568545,0.002562488,0.0002613702,0.00465085],"genre_scores_gemma":[0.9840068,0.002083926,0.001480337,0.00196914,0.0004785032,0.004679345,0.001793001,0.00003524325,0.003473646],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009249083,"threshold_uncertainty_score":0.03094131,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1300541615192752,"score_gpt":0.4476270528897659,"score_spread":0.3175728913704907,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}